Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain-Reference-Cited by-同舟云学术

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Published:2008-07-15 Issue:2 Volume:137 Page:428-440
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Webster Lynn,Jansen Jan Peter,Peppin John,Lasko Ben,Irving Gordon,Morlion Bart,Snidow Jerry,Pierce Amy,Mortensen Eric,Kleoudis Christi,Carter Eric

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference30 articles.

1. Randomized crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.;Allan;BMJ,2001

2. Alvimopan.;Azodo;Curr Opin Investig Drugs,2002

3. Are peripheral opioid antagonists the solution to opioid side effects?;Bates;Anesth Analg,2004

4. Alvimopan, a selective peripherally acting -opioid antagonist.;Camilleri;Neurogastroenterol Motil,2005

5. Treatment of opioid-induced constipation with oral naloxone: a pilot study.;Culpepper-Morgan;Clin Pharmacol Ther,1992

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis;Molecules;2023-11-24

2. Pathogenesis, Updates on Current Treatment Options and Alvimopan for Postoperative Ileus;Biosciences Biotechnology Research Asia;2023-06-30

3. Analysis of Predictive Factors for Diarrhea after the Administration of Naldemedine;Biological and Pharmaceutical Bulletin;2021-08-01

4. Enhanced recovery after cystectomy in patients with preoperative narcotic use;Canadian Urological Association Journal;2021-05-11

5. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice;Current Treatment Options in Oncology;2021-02-26